Fulgent Genetics Inc (FLGT) – Strategy, SWOT and Corporate Finance Report
- Pages: 47
- Published: May 2023
- Report Code: MLME2554796FSA
Fulgent Genetics Inc (FLGT) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians. The company offers a range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. Its major offerings include genes and panels, known mutation, genomic testing, hereditary cancer, carrier screening, tumor profiling, newborn genetics and covid-19 testing. It offers genetic tests for cardiovascular and pediatric diseases, neurological disorders, cancers, and primarily serves medical institutions, hospitals in the US, Canada, and other countries. Fulgent is headquartered in Temple City, California, the US.
Scope
• Detailed information on Fulgent Genetics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Fulgent Genetics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Fulgent Genetics Inc including a breakdown and examination of key business segments
• News about Fulgent Genetics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Fulgent Genetics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Fulgent Genetics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Fulgent Genetics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Roche Diagnostics (Shanghai) Ltd
Pathway Genomics Corp
Natera Inc
Myriad Genetics Inc
Laboratory Corp of America Holdings
InVitae Corp
GeneDX LLC
Caris Life Sciences Inc
Baylor Genetics Laboratories
Ambry Genetics Corp
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.